Skip to main content
. Author manuscript; available in PMC: 2011 May 1.
Published in final edited form as: Cancer. 2010 May 1;116(9):2266–2274. doi: 10.1002/cncr.24929

Figure 6.

Figure 6

Proposed decision scheme for clinical risk assessment of pediatric non-rhabdomyosarcoma soft tissue sarcoma incorporating mitotic figures as a discriminating feature in patients within the intermediate risk clinical group. The latter is defined as clinical group II patients with tumor size >5cm or clinical group III. This scheme does not apply to tumors whose grade is assigned a priori (see Table 8).